Previous studies revealed pharmacological differences between human and guinea pig histamine H 2 receptors (H 2 Rs) with respect to the interaction with guanidine-type agonists. Because H 2 R species variants are structurally very similar, comparative studies are suited to relate different properties of H 2 R species isoforms to few molecular determinants. Therefore, we systematically compared H 2 Rs of human (h), guinea pig (gp), rat (r), and canine (c). Fusion proteins of hH 2 R, gpH 2 R, rH 2 R, and cH 2 R, respectively, and the short splice variant of G s␣ , G s␣S , were expressed in Sf9 insect cells. In the membrane steady-state GTPase activity assay, cH 2 R-G s␣S but neither gpH 2 R-G s␣S nor rH 2 R-G s␣S showed the hallmarks of increased constitutive activity compared with hH 2 R-G s␣S , i.e., increased efficacies of partial agonists, increased potencies of agonists with the extent of potency increase being correlated with the corresponding efficacies at hH 2 R-G s␣S , increased inverse agonist efficacies, and decreased potencies of antagonists. Furthermore, in membranes expressing nonfused H 2 Rs without or together with mammalian G s␣S or H 2 R-G s␣ fusion proteins, the highest basal and GTP-dependent increases in adenylyl cyclase activity were observed for cH 2 R. An example of ligand selectivity is given by metiamide, acting as an inverse agonist at hH 2 R-G s␣S , gpH 2 R-G s␣S , and rH 2 R-G s␣S in the GTPase assay in contrast to being a weak partial agonist with decreased potency at cH 2 R-G s␣S . In conclusion, the cH 2 R exhibits increased constitutive activity compared with hH 2 R, gpH 2 R, and rH 2 R, and there is evidence for ligand-specific conformations in H 2 R species isoforms.
with the extent of potency increase being correlated with the corresponding efficacies at hH 2 R-G s␣S , increased inverse agonist efficacies, and decreased potencies of antagonists. Furthermore, in membranes expressing nonfused H 2 Rs without or together with mammalian G s␣S or H 2 R-G s␣ fusion proteins, the highest basal and GTP-dependent increases in adenylyl cyclase activity were observed for cH 2 R. An example of ligand selectivity is given by metiamide, acting as an inverse agonist at hH 2 R-G s␣S , gpH 2 R-G s␣S , and rH 2 R-G s␣S in the GTPase assay in contrast to being a weak partial agonist with decreased potency at cH 2 R-G s␣S . In conclusion, the cH 2 R exhibits increased constitutive activity compared with hH 2 R, gpH 2 R, and rH 2 R, and there is evidence for ligand-specific conformations in H 2 R species isoforms.
The histamine H 2 receptor (H 2 R) species isoforms of canine (Gantz et al., 1991b) , human (Gantz et al., 1991a) , rat (Ruat et al., 1991) , and guinea pig (Traiffort et al., 1995) were cloned. The four H 2 R species isoforms are closely related to each other, as is reflected by an overall amino acid sequence identity of more than 80%. The highest conservation exists within the seven ␣-helical transmembrane (TM) domains (sequence identity of more than 90%), whereas the N-terminal domain together with the extracellular end of TM1 and the C terminus are the least conserved regions (Fig. 1) .
Despite this high degree of structural similarity, N- [3-(1H-imidazol-4-yl) propyl]guanidines such as compounds 8 to 10 (Fig. 2 ) differentially activate guinea pig (gpH 2 R) and human (hH 2 R) H 2 receptors. In a membrane steady-state GTPase activity assay using fusion proteins of H 2 R and the short splice variant of G s␣ , G s␣S , such H 2 R-selective agonists are considerably more potent and efficacious at gpH 2 R-G s␣S than at hH 2 R-G s␣S (Kelley et al., 2001) . By contrast, the small H 2 R agonists histamine (1, HA), dimaprit (2, DIM), amthamine (3, AMT), and betahistine (4, BET) are unselective between these species. Recently, a novel class of N G -acylated imida-zolylpropylguanidines as represented by compounds 11 to 16 was developed (Ghorai, 2005; Xie et al., 2006a) . Generally, by introduction of a carbonyl group adjacent to the guanidine moiety, the species selectivity of the agonists is preserved (Xie et al., 2006a) . Comparison of the corresponding agonist efficacies in the GTPase assay and at stabilizing the highaffinity ternary complex of the H 2 R with nucleotide-free G s␣ indicate that N- [3-(1H-imidazol-4-yl) propyl]guanidines and their N G -acylated analogs stabilize different ligand-specific active conformations of hH 2 R and gpH 2 R (Kelley et al., 2001; Xie et al., 2006a) . However, it is not known whether these differences also apply for other H 2 R species isoforms. Moreover, H 2 Rs are known to be constitutively active (Alewijnse et al., 1998) , but the degree to which constitutive activity varies among several species isoforms remains elusive. To generate an expanded pharmacological profile of H 2 R species isoforms, in the present report, we compare human, guinea pig, rat, and canine H 2 Rs. Sf9 cell membranes expressing H 2 R-G s␣S fusion proteins were used to measure steady-state GTPase activity. For this purpose, we studied several classes of H 2 R ligands (Fig. 2) . HA (1) and related small H 2 R agonists DIM (2), AMT (3), and BET (4) similarly interact with the binding site of H 2 R. The amino group of HA forms an ionic interaction with in TM3, and the imidazolyl ring presumably interacts with and in TM5 (Fig. 1 ). The guanidine-type H 2 R agonists impromidine (8, IMP), arpromidine (9, ARP), and BU-E-43 (10), as well as the N G -acylated derivatives 11 to 16 share a common N- [3-(1H-imidazol-4-yl) propyl)]guanidine moiety that mimics binding of HA and thus is crucial for agonistic activity (Dove et al., 2004) . The 2-(5-methylimidazol-4-ylmethylthio)ethyl moiety of IMP and the 3-(4-fluorophenyl)-3-(2-pyridyl)propyl group of ARP are supposed to interact with a pocket formed by multiple residues in TM3, -6, and -7 (Kelley et al., 2001) . The variable side chains of the ARP derivatives 10 to 16 consist of diverse mono-or diarylalkyl groups with different chain lengths between the aromatic ring system and the guanidine group. In compound 16 (Xie et al., 2006b) , the aryl ring is replaced by a cyclohexyl moiety. Compound 13 is the pure (R)-enantiomer (eutomer). 2-Benzylhistamine (5) and suprahistaprodifen (6) represent H 1 R agonists with partial H 2 R agonism . Burimamide (7) and metiamide (22) are neutral H 2 R antagonists, whereas cimetidine (17, CIM), ranitidine (18, RAN), famotidine (19, FAM), aminopotentidine (20, APT), and iodoaminopotentidine (21, IAPT) act as inverse agonists (Hill et al., 1997; Dove et al., 2004) .
Previous studies showed that the determination of adenylyl cyclase (AC) activity in Sf9 cell membranes is a very sensitive system to elucidate differences in the constitutive activities of GPCRs (Seifert et al., 1998b) . Therefore, we also assessed AC activity in membranes expressing nonfused H 2 Rs (coupling to endogenous G s␣ -like G proteins), in membranes coexpressing H 2 R and mammalian G s␣S , and in membranes expressing H 2 R-G s␣S fusion proteins.
Materials and Methods

Materials.
The cDNA for the rH 2 R was kindly provided by Dr. R. Leurs (Leiden/Amsterdam Center for Drug Research, Department of Medicinal Chemistry, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands) (Ruat et al., 1991) . The cDNA for the cH 2 R was Comparison of the amino acid sequences of hH 2 R, gpH 2 R, rH 2 R, and cH 2 R. The amino acid sequences of hH 2 R, gpH 2 R, rH 2 R, and cH 2 R are given in the one-letter code. Dots in the sequences of gpH 2 R, rH 2 R, and cH 2 R indicate identity with hH 2 R. Amino acids shown in white with black shading represent the interaction sites of HA with the H 2 R (Gantz et al., 1992; Nederkoorn et al., 1996) . The most conserved residues (X.50 with X being the number of the TM domain, according to the Ballesteros/Weinstein nomenclature) in each TM domain are indicated in gray shading. Amino acids shown in regular font in the sequences of gpH 2 R, rH 2 R, and cH 2 R represent conservative exchanges. Amino acids shown in bold in the sequences of gpH 2 R, rH 2 R, and cH 2 R represent nonconservative exchanges. N-term, extracellular N-terminal domain of H 2 Rs; C-term, intracellular C-terminal domain of H 2 Rs; i1, i2, and i3, first, second, and third intracellular loops; e1, e2, e3, first, second, and third extracellular loops, respectively. kindly provided by Dr. I. Gantz (University of Michigan, Medical School and Ann Arbor VA Medical Center, Ann Arbor, MI) (Gantz et al., 1991b) . The generation of the baculoviruses encoding hH 2 R, gpH 2 R, hH 2 R-G s␣S , and gpH 2 R-G s␣S was described previously (Kelley et al., 2001; Houston et al., 2002) . The baculoviruses encoding G s␣S were kindly provided by Drs. R. Sunahara and A. G. Gilman (Department of Pharmacology, University of Southwestern Medical Center, Dallas, TX). The generation of pGEM-3Z-SF-␤ 1 AR-G s␣S and pVL1392-SF-␤ 1 AR-G s␣S was described previously . Compounds 11 through 15 (Ghorai, 2005; Xie et al., 2006a) and compound 16 (Xie et al., 2006b) were prepared as described previously (Ghorai, 2005) . The preparation of IMP, ARP, BU-E-43, APT, and IAPT was described previously (Dove et al., 2004) . Suprahistaprodifen and 2-benzylhistamine were synthesized as described previously (Elz et al., 2000; Seifert et al., 2003) . The structures of compounds were confirmed by analysis (C, H, N), 1 H NMR, and mass spectrometry. Purity of compounds was Ͼ98% as determined by high-performance liquid chromatography or capillary electrophoresis. The anti-FLAG Ig (M1 monoclonal antibody) was from SigmaAldrich (St. Louis, MO). The anti-G s ␣ Ig (C-terminal) was from Santa Cruz Biotechnology (Santa Cruz, CA), and the anti-His 6 Ig was from Clonetech (Mountain View, CA). [␥- 32 P]GTP (6000 Ci/ mmol), [␣- 32 P]ATP (800 Ci/mmol), and [ 3 H]dihydroalprenolol (85-90 Ci/mmol) were from PerkinElmer Life and Analytical Sciences (Boston, MA). All unlabeled nucleotides were from Roche Diagnostics (Indianapolis, IN). HA, BET, CIM, RAN, and FAM were from SigmaAldrich. AMT was from Tocris Cookson Inc. (Ballwin, MO). DIM was from Sigma/RBI (Natick, MA). Burimamide and metiamide were from Dr. W. Schunack (Free University of Berlin, Berlin, Germany). All restriction enzymes, T4 DNA ligase, and calf intestinal phosphatase were from New England Biolabs (Beverly, MA). Cloned Pfu DNA polymerase was from Stratagene (La Jolla, CA).
Construction of the cDNAs for rH 2 R and rH 2 R-G s␣S . The cDNAs encoding for the proteins were generated by sequential overlap-extension PCRs. With pGEM-3Z-SF-gpH 2 R-G s␣S as template, PCR 1A was used to amplify a DNA fragment consisting of the cleavable signal peptide from influenza hemagglutinin (S), the FLAG epitope (F) recognized by the M1 monoclonal antibody, and the start codon of the rH 2 R. The sense primer annealed with 18 bp of pGEM-3Z before the 5Ј end of SF. The antisense primer annealed with 15 bp of the 3Ј end of SF and with ATG. In PCR 1B, the cDNA encoding the rH 2 R followed by a hexahistidine tag in 3Ј position was generated. The hexahistidine tag was included to allow future purification and to provide additional protection against proteolysis (Seifert et al., 1998a) . The sense primer consisted of 15 bp of the 3Ј end of SF and the first 22 bp of the 5Ј end of the rH 2 R. The antisense primer consisted of 18 bp of the C terminus of the rH 2 R, the hexahistidine tag, the stop codon, and an XbaI site. The cDNA for the rH 2 R was extracted from pcDNA-rH 2 R after restriction digestion with HindIII and BglII and was used as template. In PCR 2, the products of PCR 1A and PCR 1B annealed in the region encoding SF and ATG. Here, the sense primer of PCR 1A and the antisense primer of PCR 1B were used. In that way, a fragment encoding SF, the rH 2 R, the hexahistidine tag, the stop codon, and an XbaI site was Structures of H 2 R agonists, partial agonists, and antagonists. 1 to 4, small H 2 R agonists; 5 and 6, H 1 R agonists with partial agonism at the H 2 R; 8 to 10, guanidine-type H 2 R agonists; 11 to 16, N G -acylated N-[3-(1H-imidazol-4-yl) propyl]guanidines with agonistic H 2 R activity; 7 and 17 to 22, H 2 R antagonists.
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obtained. This fragment was digested with SacI and XbaI and cloned into pGEM-3Z-SF-hH 2 R digested with SacI and XbaI to yield pGEM-3Z-SF-rH 2 R. pGEM-3Z-SF-rH 2 R was digested with SacI and XbaI and cloned into the baculovirus transfer vector pVL1392-SF-hH 2 R digested with SacI and XbaI. With pGEM-3Z-SF-rH 2 R as template, the sense primer of PCR 1A, and an antisense primer encoding six histidines, in PCR 3A a fragment encoding SF, the cDNA for the rH 2 R, and the hexahistidine tag was generated. In PCR 3B, a fragment encoding the hexahistidine tag, the cDNA of G s␣S , the stop codon, and an XbaI site was generated. Here, the sense primer annealed with the hexahistidine tag and the start codon of G s␣S , and the antisense primer annealed with the cDNA encoding the five C-terminal amino acids of G s␣S , the stop codon, and an XbaI site. pGEM-3Z-SF-gpH 2 R-G s␣S was used as template. In PCR 4, the products of PCRs 3A and 3B annealed in the hexahistidine region, and the sense primer of PCR 1A and the antisense primer of PCR 3B were used. In that way, the complete cDNA for the rH 2 R-G s␣S fusion protein, consisting of SF, the cDNA for the rH 2 R, the hexahistidine tag, and the cDNA of G s␣S was amplified. The product of PCR 4 was digested with SacI and BglII and cloned into pGEM-3Z-SF-␤ 1 AR-G s␣S digested with SacI and BglII. In addition, the PCR 4 product was digested with SacI and BglII and directly cloned into pVL1392-SF-␤ 1 AR-Gs␣S that was digested with SacI and BglII and treated with calf intestinal phosphatase to yield the baculovirus transfer vector pVL1392-SF-rH 2 R-G s␣S .
Construction of the cDNAs for cH 2 R and cH 2 R-G s␣S . The strategy for the generation of the cDNAs for the epitope-tagged cH 2 R and cH 2 R-G s␣S was analogous to the strategy for the generation of the cDNAs for rH 2 R and rH 2 R-G s␣S . With pGEM-3Z-SF-gpH 2 R-G s␣S as template, in PCR 1A the SF region and the start codon of the cH 2 R were amplified. The sense primer annealed with 18 bp of pGEM-3Z before the 5Ј end of SF, and the antisense primer annealed with 15 bp of the 3Ј end of SF and with ATG. In PCR 1B, the cDNA encoding the sequence for the cH 2 R followed by the hexahistidine tag in 3Ј position was generated. The sense primer consisted of 15 bp of the 3Ј end of SF and the first 21 bp of the 5Ј end of cH 2 R. The antisense primer consisted of 18 bp of the C terminus of the cH 2 R, the hexahistidine tag, the stop codon, and an XbaI site. The cDNA for the cH 2 R was extracted from CMVneo-cH 2 R after digestion with BglII and was used as template. In PCR 2, the products of PCR 1A and PCR 1B annealed in the region encoding SF and ATG. Here, the sense primer of PCR 1A and the antisense primer of PCR 1B were used. In that way, a fragment encoding SF, the cH 2 R, the hexahistidine tag, the stop codon, and an XbaI site was obtained. This fragment was digested with SacI and XbaI and cloned into pGEM-3Z-SF-hH 2 R digested with SacI and XbaI to yield pGEM-3Z-SFcH 2 R. pGEM-3Z-SF-cH 2 R was digested with SacI and XbaI and cloned into the baculovirus transfer vector pVL1392-SF-hH 2 R digested with SacI and XbaI. PCR 3 was used to generate a fragment encoding the C terminus of the cH 2 R, the hexahistidine tag, and G s␣S . The sense primer encoded the last 10 amino acids of the C terminus of the cH 2 R, the hexahistidine tag, and the start codon of G s␣S , and the antisense primer encoded the five C-terminal amino acids of G s␣S , the stop codon, and an XbaI site. Here, pGEM-3Z-SFhH 2 R-G s␣S was used as template. This fragment was digested with XhoI and XbaI and cloned into pGEM-3Z-SF-cH 2 R digested with XhoI and XbaI to yield pGEM-3Z-SF-cH 2 R-G s␣S . pGEM-3Z-SF-cH 2 RGs␣S was digested with SacI and BglII and cloned into pVL1392-SF-␤ 1 AR-G s␣S that was digested with SacI and BglII and treated with calf intestinal phosphatase to yield the baculovirus transfer vector pVL1392-SF-cH 2 R-G s␣S .
Generation of Recombinant Baculoviruses, Cell Culture, and Membrane Preparation. Recombinant baculoviruses encoding rH 2 R, cH 2 R, rH 2 R-G s␣S , and cH 2 R-G s␣S were generated in Sf9 cells using the BaculoGOLD transfection kit (BD Biosciences PharMingen, San Diego, CA) according to the manufacturer's instructions. After initial transfection, high-titer virus stocks were generated by two sequential virus amplifications. Sf9 cells were cultured in 250-ml disposable Erlenmeyer flasks at 28°C under rotation at 125 rpm in SF 900 II medium (Invitrogen, Carlsbad, CA) supplemented with 5% (v/v) fetal calf serum (Cambrex Bio Science Walkersville Inc., Walkersville, MD) and 0.1 mg/ml gentamicin (Cambrex Bio Science Walkersville Inc.). Cells were maintained at a density of 0.5 to 6.0 ϫ 10 6 cells/ml. For infection, cells were sedimented by centrifugation and suspended in fresh medium. Cells were seeded at 3.0 ϫ 10 6 cells/ml and infected with a 1:100 dilution of high-titer baculovirus stocks encoding H 2 Rs, G s␣S , and H 2 R-G s␣S fusion proteins. Cells were cultured for 48 h before membrane preparation. Sf9 membranes were prepared as described previously (Seifert et al., 1998a) , using 1 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride, 10 g/ml benzamidine, and 10 g/ml leupeptin as protease inhibitors. Membranes were suspended in binding buffer (12.5 mM MgCl 2 , 1 mM EDTA, and 75 mM Tris-HCl, pH 7.4) and stored at Ϫ80°C until use.
SDS-PAGE and Immunoblot Analysis. Membrane proteins were separated on SDS polyacrylamide gels containing 12% (w/v) acrylamide. Proteins were then transferred onto Immobilon-P transfer membranes (Millipore Corporation, Bedford, MA). Membranes were reacted with M1 antibody, anti-G s␣ Ig, or anti-His 6 Ig (1:1000 each). Immunoreactive bands were visualized by enhanced chemoluminescence (Pierce Chemical, Rockford, IL) using sheep anti-mouse IgG (M1 and anti-His 6 Ig) and donkey anti-rabbit IgG (anti-G s␣ Ig), respectively, coupled to peroxidase.
Steady-State GTPase Activity Assay. Membranes were thawed, sedimented, and resuspended in 10 mM Tris-HCl, pH 7.4. Assay tubes contained Sf9 membranes expressing H 2 R-G s␣S fusion proteins (10 g of protein/tube), 1.0 mM MgCl 2 , 0.1 mM EDTA, 0.1 mM ATP, 100 nM GTP, 0.1 mM adenylyl imidodiphosphate, 5 mM creatine phosphate, 40 g of creatine kinase, and 0.2% (w/v) bovine serum albumin in 50 mM Tris-HCl, pH 7.4, and H 2 R ligands at various concentrations. Reaction mixtures (80 l) were incubated for 2 min at 25°C before the addition of 20 l of [␥-32 P]GTP (0.1 Ci/ tube). All stock and work dilutions of [␥- 32 P]GTP were prepared in 20 mM Tris-HCl, pH 7.4. Reactions were conducted for 20 min at 25°C. Preliminary studies under basal conditions and with HA, IMP, and ARP showed that under these conditions, GTP hydrolysis was linear. Reactions were terminated by the addition of 900 l of slurry consisting of 5% (w/v) activated charcoal and 50 mM NaH 2 PO 4 , pH 2.0. Charcoal absorbs nucleotides but not P i . Charcoal-quenched reaction mixtures were centrifuged for 7 min at room temperature at 15,000g. Six hundred microliters of the supernatant fluid of reaction mixtures was removed, and 32 P i was determined by liquid scintillation counting. Enzyme activities were corrected for spontaneous degradation of [␥- 32 P]GTP. Spontaneous [␥-32 P]GTP degradation was determined in tubes containing all of the above-described components plus a very high concentration of unlabeled GTP (1 mM) that, by competition with [␥- 32 P]GTP, prevents [␥-32 P]GTP hydrolysis by enzymatic activities present in Sf9 membranes. Spontaneous [␥- 32 P]GTP degradation was Ͻ1% of the total amount of radioactivity added using 20 mM Tris-HCl, pH 7.4, as solvent for [␥- 32 P]GTP. The experimental conditions chosen ensured that not more than 10% of the total amount of [␥-32 P]GTP added was converted to 32 P i . AC Activity Assay. AC activity in Sf9 membranes was determined as described previously (Houston et al., 2002) . In brief, membranes were thawed and sedimented by a 15-min centrifugation at 4°C and 15,000g to remove residual endogenous guanine nucleotides as far as possible, and they were subsequently resuspended in binding buffer. Tubes contained Sf9 membranes expressing H 2 Rs (100 g of protein/tube), H 2 Rs coexpressed with mammalian G s␣S (50 g of protein/tube), or H 2 R-G s␣S fusion proteins (20 g of protein/tube), additionally 5 mM MgCl 2 , 0.4 mM EDTA, and 30 mM Tris-HCl, pH 7.4. Assay tubes containing membranes and various additions in a total volume of 30 l were incubated for 3 min at 37°C before starting reactions by the addition of 20 l of reaction mixture containing (final) [␣- 32 P]ATP (0.3 Ci/tube) plus 40 M unlabeled ATP, 2.7 mM mono(cyclohexyl)ammonium phosphoenolpyruvate, 0.125 IU of pyruvate kinase, 1 IU of myokinase, and 0.1 mM cAMP. Reactions were 986 conducted for 20 min at 37°C. Reactions were terminated by the addition of 20 l of 2.2 N HCl. Denatured protein was sedimented by a 3-min centrifugation at 25°C and 15,000g. Sixty-five microliters of the supernatant fluid was applied onto disposable columns filled with 1.3 g of neutral alumina (Sigma A-1522, super I, 3 H]Dihydroalprenolol saturation binding was performed as described previously (Seifert et al., 1998a) . All analyses of experimental data were performed with the Prism 4 program (GraphPad Software Inc., San Diego, CA). K B values were calculated using the Cheng and Prusoff equation (1973) equation. Expression levels of recombinant proteins were determined using the Bio-Rad GS-710 calibrated imaging densitometer and the software tool Quantity One, version 4.0.3 (Bio-Rad).
Results
Immunological Detection of Recombinant Proteins in Sf9
Cell Membranes. The predicted molecular mass of the H 2 R is ϳ33 kDa (Gantz et al., 1991a,b; Fukushima et al., 1997) . H 2 R species isoforms presumably exhibit similar glycosylation patterns, because the putative N-glycosylation sites for the H 2 R, Asn-4, and Asn-162 are fully conserved within their sequences ( Fig. 1) (Fukushima et al., 1995) . However, only rH 2 R and hH 2 R migrated as the expected bands for monomeric GPCRs (Fig. 3, A and B) . Both bands occur as doublets, representing different glycosylation forms (Houston et al., 2002) . Additional bands were detected at ϳ70 kDa, presumably representing receptor dimers. A similar pattern of immunoreactive bands was previously observed for the hH 2 R (Houston et al., 2002) . In contrast, both cH 2 R and gpH 2 R displayed strong doublet bands at ϳ60 kDa that coincide with the expected bands of differentially glycosylated H 2 R dimers, whereas the bands for monomers were absent. Additional bands were detected at ϳ150 kDa and above 250 kDa, possibly corresponding to H 2 R tetramers and higher oligomers, respectively. Dimerization and oligomerization of the cH 2 R has been described previously (Fukushima et al., 1997) , but in those experiments, also receptor monomers were detected. Hence, gpH 2 R and cH 2 R possibly migrated atypically in SDS-PAGE, i.e., the bands at ϳ60 and ϳ150 kDa could correspond to monomers and dimers, respectively, and not to dimers and tetramers. With the anti-His 6 Ig, in membranes expressing cH 2 R, an additional doublet band at ϳ23 kDa was detected, and in rH 2 R-and hH 2 R membranes, an ϳ27-kDa band was present. However, no such bands were detected in gpH 2 R membranes. The ϳ23-27-kDa bands may represent differentially and atypically migrating H 2 R monomers not recognized by the M1 antibody because of a lack of epitope exposure. By analogy to formyl peptide receptors differences in the C termini of H 2 R species isoforms may constitute the molecular basis for the species-selective migration pattern. Thus, H 2 R species isoforms are well expressed in Sf9 membranes, but due to their widely different migration, it is impossible to precisely assess their expression levels using ␤ 2 AR-membranes calibrated with [ 3 H]dihydroalprenolol saturation binding as standard (Kelley et al., 2001 ).
H 2 R-G s␣S fusion proteins of canine, rat, guinea pig, and human occurred as strong bands at ϳ80 kDa (Fig. 3C) . Because G s␣S has an apparent molecular mass of ϳ45 kDa, these bands correspond to H 2 R-G s␣S monomers. Weaker   Fig. 3 . Immunological detection and analysis of the expression of recombinant proteins in Sf9 cells. Sf9 membranes expressing various proteins were prepared, separated by SDS-PAGE on gels containing 12% (w/v) acrylamide, transferred onto Immobilon-P membranes, and probed with the respective Ig indicated on top of each panel. In each lane, 10 g of membrane protein was loaded onto the gel, unless otherwise indicated below membranes. Exceptionally, 40 g of a membrane expressing gpH 2 R-G s␣S were loaded onto the gels in C and D. Numbers on the left of membranes designate masses of marker proteins in kilodaltons. In A and C, 1, 2, 5, and 10 g of protein of Sf9 membranes expressing the ␤ 2 AR at 7.5 pmol mg Ϫ1 (as determined by [ 3 H]DHA saturation binding) were used as standard to assess the expression levels of H 2 R species isoforms. In D, membranes expressing H 2 R-G s␣S fusion proteins and membranes coexpressing H 2 R species and mammalian G s␣S were loaded onto the gel.
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bands were detected at ϳ110 kDa, most probably representing differently glycosylated fusion proteins. With all species, additional bands at ϳ250 kDa were detected, presumably representing H 2 R-G s␣S dimers or oligomers. cH 2 R-G s␣S was expressed at ϳ5 pmol mg Ϫ1 , rH 2 R-G s␣S at ϳ4 pmol mg Ϫ1 , gpH 2 R-G s␣S at ϳ1 pmol mg Ϫ1 , and hH 2 R-G s␣S at ϳ3 pmol mg Ϫ1 using ␤ 2 AR-membranes as standard. To account for the decreased expression level of gpH 2 R-G s␣S , in this case the amount of protein applied to the gel was adjusted to 40 g.
Probing membranes expressing H 2 R-G s␣S species with the anti-G s␣ Ig yielded ϳ80-and ϳ250-kDa bands (Fig. 3D) , which are consistent with those bands observed with the anti-FLAG Ig. Additional bands occurred at ϳ45 kDa, representing atypically migrating or partially degraded fusion proteins. In all membranes coexpressing H 2 R species and G s␣S , the expected bands for G s␣S monomers were detected at ϳ45 kDa. The expression levels of G s␣S in membranes coexpressing H 2 R and G s␣S were estimated using the ϳ80-kDa peak intensities of H 2 R-G s␣S species as standard and were ϳ2 pmol mg Ϫ1 in membranes coexpressing cH 2 R and G s␣S , ϳ2 pmol mg Ϫ1 in membranes coexpressing rH 2 R and G s␣S , ϳ1 pmol mg Ϫ1 in membranes coexpressing gpH 2 R and G s␣S , and ϳ1 pmol mg Ϫ1 in membranes coexpressing hH 2 R and G s␣S . Efficacies and Potencies of Agonists at H 2 R-G s␣S Species Isoforms Derived from the GTPase Assay. Efficacies and potencies of compounds 1 to 22 at H 2 R-G s␣S fusion proteins of human, guinea pig, rat, and canine are summarized in Table 1 . The small H 2 R agonists acted as full (1-3) or as nearly full (4) agonists at the four receptors with approximately similar efficacies. HA (1) and DIM (2) were equipotent at human, guinea pig, and rat H 2 R-G s␣S , they but showed lower EC 50 values at cH 2 R-G s␣S . AMT (3) was slightly more potent at cH 2 R-G s␣S than at hH 2 R-G s␣S and gpH 2 R-G s␣S . At rH 2 R-G s␣S , the potency of AMT (3) was further decreased. BET (4) acted with increased potencies at gpH 2 R-G s␣S and cH 2 R-G s␣S , compared with hH 2 R-G s␣S and rH 2 R-G s␣S . In agreement with previous studies (Kelley et al., 2001; Xie et al., 2006a,b), N-[3-(1H-imidazol-4-yl) propyl]guanidines (8-10) and their N G -acylated analogs (11-16) were more potent and more efficacious at gpH 2 R-G s␣S than at hH 2 R-G s␣S (Table 1) . At gpH 2 R-G s␣S , UR-PG222A (13) was more efficacious than HA (1). At hH 2 R-G s␣S and rH 2 R-G s␣S , the compounds exhibited similar efficacies and potencies. Only UR-PG214 (11) was slightly more potent at rH 2 R-G s␣S than at hH 2 R-G s␣S . Apart from ARP (9) and its N G -acylated analog UR-PG136 (15) that acted with similar efficacies at cH 2 R-G s␣S and hH 2 R-G s␣S , compounds 8 to 16 were more efficacious at cH 2 R-G s␣S than at hH 2 R-G s␣S . Compounds 8 to 16 were also more potent at cH 2 R-G s␣S than at hH 2 R-G s␣S . An exception of this rule was UR-PG123 (14) that exhibited the largest efficacy increase (ϳ4-fold) but was somewhat less potent at cH 2 R-G s␣S than at hH 2 R-G s␣S . In summary, small H 2 R agonists 1 to 4 acted with similar efficacies at all H 2 R-G s␣S species isoforms investigated, but they were more potent at cH 2 R-G s␣S compared with hH 2 R-G s␣S , gpH 2 R-G s␣S , and rH 2 R-G s␣S . Guanidines and N G -acylated guanidines 8 to 16 acted with increased efficacies and potencies at gpH 2 R-G s␣S and cH 2 R-G s␣S compared with hH 2 R-G s␣S , whereas no selectivity was observed between rH 2 R-G s␣S and hH 2 R-G s␣S .
Compounds 5 and 6 are representatives of H 1 R agonists with partial H 2 R agonism . Both compounds were less efficacious at gpH 2 R-G s␣S than at hH 2 R-G s␣S and similarly efficacious at rH 2 R-G s␣S and hH 2 R-G s␣S (Table 1 ). In the GTPase assay at H 2 R-G s␣S fusion proteins, burimamide (7) was a weak partial agonist with similar efficacies at human, guinea pig, and rat species. Strikingly, compounds 5, 6, and 7 acted with significantly increased efficacies at cH 2 R-G s␣S compared with hH 2 R-G s␣S . Apart from 2-benzylhistamine (5) with ϳ2-fold increased potency at gpH 2 R-G s␣S , the potencies of 5 to 7 did not significantly differ between the species investigated. Taken together, partial H 2 R agonists were considerably more efficacious at cH 2 R-G s␣S than at human, guinea pig, and rat H 2 R-G s␣S .
Potencies Table 2 . The compounds decreased GTPase activities below basal values and thus acted as inverse agonists at all four species. At hH 2 R-G s␣S and gpH 2 R-G s␣S compounds 17 to 21 decreased the basal GTPase signal (0%) by ϳ10% if the maximal stimulatory effect of 100 M HA was set to 100%. At rH 2 R-G s␣S the inverse agonist efficacies of 17 to 21 were somewhat smaller. At cH 2 R-G s␣S all compounds except CIM (17) showed a significantly higher reduction of the basal GTPase activity by ϳ20%. The K B values of 17 to 21 were similar at hH 2 R-G s␣S and gpH 2 R-G s␣S . At rH 2 R-G s␣S , 17 to 19 were less potent, and 20 and 21 were similarly potent compared with hH 2 R-G s␣S . By contrast, all compounds except FAM (19) were less potent at cH 2 R-G s␣S than at hH 2 R-G s␣S . Taken together, most of the H 2 R antagonists studied displayed increased inverse agonist efficacies and decreased potencies at cH 2 R-G s␣S compared with hH 2 R-G s␣S .
Constitutive Activities of hH 2 R-G s␣S , gpH 2 R-G s␣S , rH 2 R-G s␣S , and cH 2 R-G s␣S in the GTPase Assay. As was reported for a constitutively activated mutant of the ␤ 2 AR , the following major hallmarks distinguish constitutively active GPCRs from not (quiescent) or less constitutively active GPCRs. First, the efficacies of partial agonists are increased at the more constitutively active receptor. To uncover differences in the constitutive activities among H 2 R-G s␣S species, efficacies of partial and full agonists 1 to 16 and inverse agonist efficacies of antagonists 17 to 21 were compared at hH 2 R-G s␣S with gpH 2 R-G s␣S , rH 2 R-G s␣S , and cH 2 R-G s␣S , respectively (Fig. 4 , A, C, and E). Second, constitutively active receptors exhibit an increased affinity for agonists but not antagonists, with the extent of affinity increase being correlated with the efficacy of the ligand . Essentially, the potencies in the GTPase assay represent apparent affinities and can be therefore related, as logEC 50 differences between hH 2 R-G s␣S and the other H 2 R species isoforms, to the corresponding efficacies at hH 2 R-G s␣S (Fig. 4, B, D, and F) . Finally, at receptors with increased constitutive activity inverse agonists have an elevated inhibitory effect on GTP hydrolysis (Seifert et al., 1998b) .
Similar inverse agonist efficacies of antagonists 17 to 21 and the absence of selectivity in the efficacies of partial agonists 5 to 7 and 14 indicate equal magnitudes of constitutive activities for gpH 2 R-G s␣S and hH 2 R-G s␣S (Fig. 4A) . As  Fig. 4B illustrates, a poor but significant correlation (r 2 ϭ 0.27; p ϭ 0.016) was observed between the log (potency ratio) of these species and the efficacies of compounds 1 to 21 at 
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hH 2 R-G s␣S . However, this correlation was determined by ligand-specific interactions, namely, the high potencies of guanidines (8 to 10) and N G -acylguanidines (11 to 16) at gpH 2 R-G s␣S (Kelley et al., 2001; Xie et al., 2006a,b) , and disappeared if only compounds 1 to 7 and 17 to 21 were considered (r 2 ϭ 0.04; p ϭ 0.527). The efficacies of compounds 1 to 21 at rH 2 R-G s␣S and hH 2 R-G s␣S were almost identical (Fig. 4C) . Moreover, no correlation between the log (potency ratio) and the efficacies at hH 2 R-G s␣S was evident (r 2 ϭ 0.16; p ϭ 0.077) (Fig. 4D) . Thus, in the steady-state GTPase assay, rH 2 R-G s␣S and hH 2 R-G s␣S exhibited similar levels of constitutive activities. By contrast, cH 2 R-G s␣S showed the hallmarks of a GPCR with increased constitutive activity compared with hH 2 R-G s␣S . Specifically, partial agonists 5 to 7 and 14 were considerably more efficacious at cH 2 R-G s␣S and the inverse agonist efficacies of antagonists 18 to 21 were increased compared with hH 2 R-G s␣S (Fig. 4E) . A highly significant correlation between the log (potency ratio) and the efficacies of compounds 1 to 21 at hH 2 R-G s␣S was determined (r 2 ϭ 0.77; p Ͻ 0.0001; Fig. 4F ). It is noteworthy that this correlation was independent of distinct interactions of guanidines and N G -acylguanidines with cH 2 R-G s␣S as omitting compounds 8 to 16 did not change the fit (r 2 ϭ 0.75; p ϭ 0.0003).
Ambiguous Response of Metiamide (22) in the GTPase Assay. At hH 2 R-G s␣S , metiamide (22) decreased the basal GTPase signal by 8 Ϯ 1% and thus acted as weak inverse agonist (Table 1 ; Fig. 5 ). At gpH 2 R-G s␣S and rH 2 R-G s␣S , metiamide inhibited the basal GTPase signals by 6 Ϯ 1 and 4 Ϯ 1%, respectively, and was ϳ2-fold more potent than at hH 2 R-G s␣S . Intriguingly, at cH 2 R-G s␣S metiamide did not act as an inverse agonist but rather as a very weak partial agonist (efficacy of 6 Ϯ 1%). This is in marked contrast to the results of antagonists 18 to 21 reducing the basal GTPase signal at cH 2 R-G s␣S (increased constitutive activity) more effectively than at the other less constitutively active species. Furthermore, the potency of 22 was lowered by approximately 15-fold compared with hH 2 R-G s␣S and not increased as would have been expected for a partial agonist . Attempts to detect changes in AC activity upon stimulation with metiamide in membranes coexpressing cH 2 R and G s␣S failed due to the much lower sensitivity of this system compared with the GTPase activity assay using fusion proteins (data not shown).
Regulation of AC Activities in Membranes Expressing Fused and Nonfused H 2 R Species
Isoforms. AC activity was measured in Sf9 cell membranes expressing H 2 Rs (coupling to endogenous G s␣ -like G proteins), in membranes coexpressing H 2 R and mammalian G s␣S , and in membranes expressing H 2 R-G s␣S fusion proteins. Basal AC activities were similar in membranes expressing hH 2 R, gpH 2 R, and rH 2 R (Table 3 ) and ϳ2-fold higher in the case of the cH 2 R. GTP (10 M) by itself increased AC activities at all four H 2 R species by ϳ2-fold above the basal level. HA (1) further increased, and IAPT (21) inhibited this GTP-dependent signal increase, indicative for constitutive activity of all four H 2 R species isoforms in Sf9 membranes (Fig. 6, A-D) . These observations are in agreement with previous studies at the ␤ 2 AR (Seifert et al., 1998a) . The stimulatory effects of GTP, as determined by relating the effects of GTP (10 M) to the effects of HA (100 M) plus GTP (10 M), were largest at cH 2 R and rH 2 R, compared with hH 2 R and gpH 2 R. Both the high basal AC activity and the strong stimulation with GTP indicate an elevated level of constitutive activity in membranes expressing the cH 2 R relative to membranes expressing hH 2 R, gpH 2 R, and rH 2 R. It is noteworthy that the constitutive activity of rH 2 R seemed to be slightly increased compared with hH 2 R and gpH 2 R.
The GPCR/G protein stoichiometry affects the magnitude of response (Kenakin, 2001) . In H 2 R membranes coexpressing mammalian G s␣S , 5-to 18-fold increased basal levels of AC activity were measured relative to membranes expressing H 2 R alone (Table 3) . Basal AC activities were ϳ6-fold higher at cH 2 R plus G s␣S and ϳ2-fold higher at rH 2 R plus G s␣S , respectively, compared with hH 2 R plus G s␣S . With gpH 2 R plus G s␣S , the basal AC activity was somewhat lower than with hH 2 R plus G s␣S . As was observed in membranes expressing H 2 R alone, the highest stimulatory effects of GTP in the coexpression system were observed with cH 2 R and rH 2 R compared with gpH 2 R and hH 2 R. The inverse agonist IAPT (10 M) decreased the GTP-dependent increases of AC activity at all species isoforms (Fig. 6, E-H) , but even strongly reduced basal AC activities at the lowest concentrations of added GTP. These effects were probably due to traces of GDP being converted to GTP by the action of nucleoside diphosphate kinase and were most prominent in membranes expressing cH 2 R plus G s␣S (ϳ69% reduction below basal) and rH 2 R plus G s␣S (ϳ59% reduction), compared with hH 2 R plus TABLE 2 Potencies and inverse agonist efficacies of antagonists at H 2 R-G s␣S species isoforms in the GTPase assay Steady-state GTPase activity in Sf9 membranes expressing hH 2 R-G s␣S , gpH 2 R-G s␣S , rH 2 R-G s␣S , and cH 2 R-G s␣S was determined as described under Materials and Methods. Reaction mixtures contained Sf9 membranes expressing fusion proteins, 1 M HA as agonist and antagonists at concentrations from 1 nM to 100 M as appropriate to generate saturated competition curves. Competition curves were analyzed by nonlinear regression. To determine the inverse agonist efficacies (Inv. Ago. Eff.), the effects of antagonists at fixed concentrations (10 M of 18 -21; 100 M of 17) on basal GTPase activity were assessed and referred to the stimulatory effect of 100 M HA (ϭ1.00). Data shown are the means Ϯ S.D. of three experiments performed in duplicates. K B values and inverse agonist efficacies, respectively, of antagonists at hH 2 R-G s␣S were compared with the corresponding parameters at gpH 2 R-G s␣S , rH 2 R-G s␣S , and cH 2 R-G s␣S , respectively, using one-way ANOVA. The control data for hH 2 R-G S␣S and gpH 2 R-G S␣S are identical with the control data for these constructs in Table 2 of Preuss et al. (2007 
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G s␣S (ϳ29% reduction) and gpH 2 R plus G s␣S (ϳ23% reduction). Taken together, among H 2 R species isoforms coexpressed with G s␣S , cH 2 R was the most constitutively active GPCR. Due to the efficient coupling of the signaling partners in GPCR-G s ␣ fusion proteins (Seifert et al., 1999) , in membranes expressing H 2 R-G s␣S , strongly elevated basal AC activities were measured, compared with membranes expressing nonfused H 2 Rs coexpressing G s␣S (Table 3 ). In agreement with the results obtained for membranes expressing nonfused H 2 Rs, among the four species isoforms, cH 2 R-G s␣S and rH 2 R-G s␣S exhibited the highest basal AC activities. As shown in Fig. 6 , K and L, GTP increased AC activity in those membranes so effectively that HA could not produce a further increase, reflecting exhaustion of the limiting pool of AC molecules (Seifert at al., 1998a) . At hH 2 R-G s␣S and gpH 2 R-G s␣S , GTP induced only smaller increases, allowing HA to further enhance AC activity. By contrast, in the absence of added GTP, HA (100 M) yielded a reduction of basal AC activities at all four species (Fig. 6, I-L) . Very similar effects were observed previously for the ␤ 2 AR-G s␣S fusion protein (Seifert et al., 1998b) and are due to dissociation of GDP from G s␣S following agonist binding to the receptor without subsequent binding of GTP. Because G s␣-GDP is more effective in activating AC than nucleotide-free G s␣ , AC activity was reduced below basal. Due to much less efficient coupling in membranes coexpressing receptors and G s␣S (Seifert et al., 1998a; Houston et al., 2002; Gille and Seifert, 2003) , in this case HA did not reduce basal AC activity (Fig. 6, E-H ). Similar differences in the coupling efficiencies between fusion proteins and nonfused expression systems were observed in terms of ternary complex formation, guanosine 5Ј-O-(3-thio)triphosphate binding, GTP hydrolysis, and AC activation in the presence of GTP (Seifert et al., 1998a; Wenzel-Seifert et al., 2002; Gille and Seifert, 2003) . Thus, in membranes expressing H 2 R-G s␣S fusion proteins the apparent constitutive activities were considerably higher than in membranes expressing nonfused H 2 Rs. In the case of cH 2 R-G s␣S and rH 2 R-G s␣S , saturation of AC molecules became manifest upon agonist (HA) stimulation.
Discussion
Increased Constitutive Activity of the cH 2 R Compared with hH 2 R, gpH 2 R, and rH 2 R. The use of GPCR- Fig. 4 . Efficacies and potencies of ligands 1 to 21 at hH 2 R-G s␣S in pairwise comparison with gpH 2 R-G s␣S , rH 2 R-G s␣S , and cH 2 R-G s␣S , respectively, as determined in the steady-state GTPase assay. GTPase activity in Sf9 membranes was measured as described under Materials and Methods. Data shown are the means taken from Tables 1 and 2 . A, C, and E, relation between the efficacies of compounds 1 to 21 at hH 2 R-G s␣S versus gpH 2 R-G s␣S (A), rH 2 R-G s␣S (C), and cH 2 R-G s␣S (E), respectively. The dashed line has a slope of 1.0 and represents a theoretical curve of identical efficacies in both systems. B, D, and F, relation between log (potency ratio) of compounds 1 to 21 at gpH 2 R-G s␣S (B), rH 2 R-G s␣S (D), and cH 2 R-G s␣S (F), respectively, and the corresponding efficacies at hH 2 R-G s␣S . The potency ratio is the ratio of EC 50 values of full and partial agonists (1-16) at hH 2 R-G s␣S and at gpH 2 R-G s␣S , rH 2 R-G s␣S , and cH 2 R-G s␣S , respectively. Accordingly, the potency ratio of antagonists (17-21) is the ratio of the corresponding K B values at hH 2 R-G s␣S and at gpH 2 R-G s␣S , rH 2 R-G s␣S , and cH 2 R-G s␣S , respectively. The vertical dashed line intersects the abscissa at 0.0 and represents a theoretical curve of identical potencies in both systems. Fig. 5 . Effects of metiamide on GTPase activity in membranes expressing H 2 R-G s␣S species isoforms. GTPase activity in Sf9 membranes was determined as described under Materials and Methods. Reaction mixtures contained membranes (10 g of protein/tube) expressing hH 2 R-G s␣S , gpH 2 R-G s␣S , rH 2 R-G s␣S , and cH 2 R-G s␣S fusion proteins and metiamide at concentrations indicated on the abscissa. Data are expressed as percentage change in GTPase activity induced by metiamide compared with the GTPase activity stimulated by HA (100 M). Data shown are the means Ϯ S.E.M. of three independent experiments performed in duplicates. Data were analyzed by nonlinear regression and were best fitted to sigmoidal concentration-response curves. The significance of the deviation from zero was calculated for each mean value using t test; ‫,ء‬ p Ͻ 0.05; ‫,ءء‬ p Ͻ 0.01; ‫,ءءء‬ p Ͻ 0.001.
Analysis of H 2 R Species Isoforms
G s␣ fusion protein in combination with the determination of GTPase activity in Sf9 cell membranes was previously shown to be an appropriate system to quantify constitutive activity (Seifert et al., 1998b; Seifert and Wenzel-Seifert, 2002) . This system fixes GPCR/G protein coupling and stays at a proximal level, thus avoiding potential bias caused by more downstream effects, such as effector activation or changes in gene expression. Moreover, due to the defined 1:1 stoichiometry of receptor and G s␣ in fusion proteins, ligand potencies and efficacies in the steady-state GTPase assay are independent of the expression levels, allowing for the comparison of various membrane preparations with different expression levels (Seifert et al., 1999; Milligan, 2000) .
We comprehensively characterized the human, guinea pig, rat, and canine H 2 R species isoforms in steady-state GTPase assays in Sf9 cell membranes expressing H 2 R-G s␣S fusion proteins. Structurally diverse H 2 R full and partial agonists and antagonists unmasked considerable differences in the constitutive activities of the receptors. Specifically, cH 2 R-G s␣S but neither rH 2 R-G s␣S nor gpH 2 R-G s␣S displayed the hallmarks of increased constitutive activity compared with hH 2 R-G s␣S Samama et al., 1993) : 1) increased efficacies of partial agonists, 2) increased potencies of agonists with the extent of potency increase being correlated with the efficacy, and 3) increased inverse agonist efficacies and decreased potencies of antagonists.
The determination of AC activity in Sf9 cell membranes is an alternative and sensitive method to investigate constitutive activity of GPCRs (Seifert et al., 1998a) . With respect to AC, differences in the basal activity and in the magnitudes of signal increases upon stimulation with GTP are indicators for various levels of constitutive activity. In the AC activity assay with membranes expressing nonfused H 2 R species isoforms either without or together with mammalian G s␣S , both effects were most pronounced for canine relative to human, guinea pig, and rat, corroborating the outstanding role of cH 2 R in terms of constitutive activity.
However, our analysis of AC activity in membranes expressing H 2 R species isoforms also illustrates the limitations of this system. Most importantly, the low concentration levels of AC molecules constrain the maximal signal output, thereby yielding large stimulatory effects of GTP and large inhibitory effects of inverse agonists on AC activity. In contrast, the stimulatory effects of the agonist HA are small, if at all detectable. In addition, in the case of the rH 2 R, basal AC activities and the increases of AC activity upon stimulation with GTP were moderately higher compared with the hH 2 R, whereas in the GTPase activity assay rH 2 R-G s␣S and hH 2 R-G s␣S showed similar constitutive activity. The accumulation of rH 2 R in Sf9 cell membrane microdomains rich in AC molecules could be an explanation for the observed effects (Ostrom and Insel, 2004) .
It is now widely accepted that GPCR activation involves disruption of an ionic lock between Asp(3.49) and Arg(3.50) of the highly conserved (E/D)RY motif in TM3 and Glu(6.30) in the cytoplasmatic extension of TM6 (Ballesteros et al., 2001; Visiers et al., 2002) . The effects of mutations in the DRY motif on constitutive activity and structural instability of the rat H 2 R were shown previously (Alewijnse et al., 2000) . , , and Glu-228/229(6.30) are conserved among all H 2 R species isoforms. However, preceding Glu-229(6.30) in hH 2 R and gpH 2 R and the corresponding Glu-228(6.30) in rH 2 R, human, guinea pig, and rat H 2 Rs exhibit an arginine (6.29), compared with a glycine (6.29), in cH 2 R. Strikingly, many class A GPCRs contain a basic amino acid at the corresponding position, and accordingly, a stabilizing role of this residue in the network of ionic interactions was proposed (Ballesteros et al., 2001) . Hence, the lack of this additional constraint in cH 2 R could facilitate the transition from the inactive to the active state, resulting in the observed enhancement in constitutive activity.
Other differences in amino acid sequences could contribute to the differences in constitutive activity as well. Specifically, in G649, an allelic variant of the hH 2 R, Asn-217 in i3, is replaced by Asp-217. This mutant displays low basal activity and is resistant to up-regulation upon antagonist exposure (Fukushima et al., 2001 ). Intriguingly, Asn-217 is conserved within hH 2 R, gpH 2 R, and rH 2 R, but it is replaced by a histidine in cH 2 R. Moreover, major variations in the sequences of H 2 R species isoforms occur in the C-terminal domain. Because the C terminus of H 2 R is important for G s protein activation (Smit et al., 1996) , the observed variations in the constitutive activities may alternatively or additionally be due to differences in this domain. In fact, an influence of the TABLE 3 AC activities in Sf9 membranes expressing H 2 R species isoforms without or with G s␣S , and in Sf9 membranes expressing H 2 R-G s␣S fusion proteins Basal AC activities and the effects of GTP and HA on AC activity were assessed. AC activity in Sf9 membranes was determined as described under Materials and Methods. Reaction mixtures contained Sf9 membranes expressing 20 to 100 g protein/tube as appropriate and distilled water (basal), GTP (10 M), or GTP (10 M), and HA (100 M). Data shown are the means Ϯ S.D. of three to four experiments performed in triplicates. To calculate the stimulatory effect of GTP (Rel. GTP Effect), the effect of GTP (10 M) was referred to the effect of GTP (10 M) plus HA (100 M). The control data for hH 2 R-G S␣S and gpH 2 R-G S␣S are identical with the control data for these constructs in Table 3 of Preuss et al. (2007 
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C terminus on the constitutive activities of various GPCRs was described previously (Prezeau et al., 1996; WenzelSeifert and Seifert, 2003) . Ligand-Specific Interactions at H 2 R Species Isoforms. In the GTPase activity assay, N- [3-(1H-imidazol-4-yl) propyl]guanidines and their N G -acylated analogs were more potent and more efficacious at gpH 2 R-G s␣S than at hH 2 R-G s␣S , which is in agreement with previous studies (Kelley et al., 2001; Xie et al., 2006a) . Because both species isoforms exhibit similar constitutive activities, our present data further support the concept of distinct interactions as a rationale for this species selectivity. As was predicted by molecular modeling studies and subsequently verified by site-directed mutagenesis, the species selectivity of guanidine-type agonists is based on two distinct amino acids, Tyr-17(1.31) in TM1 and Asp-271(7.36) in TM7 in the gpH 2 R, presumably interacting via a charge assisted H-bond and thereby stabilizing an active agonist-bound conformation (Kelley et al., 2001 ). In the hH 2 R [Cys-17(1.31), Ala-271(7.36)] and the rH 2 R [Leu-17(1.31), Gly-270(7.36)], this interaction is impossible. Consistently, the guanidinetype agonists were similarly efficacious and potent at rH 2 R-G s␣S and hH 2 R-G s␣S . Both cH 2 R and hH 2 R contain Cys-17(1.31) and ) and the differences in potencies and efficacies of the compounds between cH 2 R-G s␣S and hH 2 R-G s␣S were not specific to the guanidines. Thus, these Table 3 . Data were analyzed by nonlinear regression and were best fitted to sigmoidal concentrationresponse curves. The control data for hH 2 R-G S␣S and gpH 2 R-G S␣S are identical with the control data for these constructs in Fig. 4 of Preuss et al. (2007) .
Analysis of H 2 R Species Isoforms differences can be explained by the increased constitutive activity of cH 2 R-G s␣S rather than by distinct ligand/GPCR interactions.
Recently, certain N G -acylated guanidines have shown to be more efficacious than HA at gpH 2 R-G s␣S in the GTPase assay (Xie et al., 2006b ), similar to the observations made with UR-PG222A (13) in the present study. These effects can be attributed to the concept of ligand-specific gpH 2 R conformations as well, i.e., these compounds stabilize active gpH 2 R conformations that lead to more efficient interactions with G s␣S than achieved with the endogenous ligand HA. By analogy, at the ␤ 2 AR labeled with a fluorescent probe, the synthetic ligand isoproterenol induced a stronger change in fluorescence intensity than the endogenous ligand norepinephrine (Swaminath et al., 2004) .
A further example of ligand-specific interactions at H 2 R species isoforms is given by metiamide, acting as a weak partial agonist with low potency at cH 2 R-G s␣S in the GTPase assay compared with being an inverse agonist with increased potency at human, guinea pig, and rat H 2 R-G s␣S . Moreover, in contrast to increased inverse agonist efficacies of antagonists 18 to 21 at cH 2 R-G s␣S relative to hH 2 R-G s␣S , gpH 2 R-G s␣S , and rH 2 R-G s␣S , the inverse agonist efficacies of cimetidine (17), a cyanoguanidine analog of metiamide, were similar at all four species whereas its potency was significantly decreased at cH 2 R-G s␣S . Presumably because of the common 2[(5-methylimidazol-4-yl)methylthio]ethyl moiety, both metiamide and cimetidine stabilize distinct conformations in cH 2 R relative to the other species isoforms, thus leading to an altered interaction with G s␣S , which, in the extreme case of metiamide, causes weak partial agonism rather than increased inverse agonism.
Conclusions
In the present study, we demonstrate that the cH 2 R exhibits increased constitutive activity compared with hH 2 R, gpH 2 R, and rH 2 R. Species-specific differences in constitutive activity were previously reported for the cholecystokinin-B/ gastrin receptor that, like the H 2 R, stimulates gastric H ϩ production (Kopin et al., 2000) . Thus, differences in constitutive activities of GPCRs regulating H ϩ production may reflect species-specific requirements for "basal" and peak H ϩ secretion in the stomach. For example, following stimulation with HA, gastric acid secretion rates in dogs exceed those of the human (Kararli, 1995) . Moreover, by studying the H 2 R antagonist metiamide, further evidence for ligand-specific conformations of H 2 R species isoforms was obtained. Our present study validates the notion that quantitative comparison of species isoforms of GPCRs provides unique insights into the molecular mechanisms of GPCR activation and ligand/GPCR interactions.
